SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹87,693 Cr | ₹81,396 Cr | ₹77,225 Cr | ₹66,958 Cr | ₹64,110 Cr |
What is the latest Total Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹87,693 Cr |
| Mar2024 | ₹81,396 Cr |
| Mar2023 | ₹77,225 Cr |
| Mar2022 | ₹66,958 Cr |
| Mar2021 | ₹64,110 Cr |
How is Total Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹87,693 Cr | 7.74 | |
| Mar2024 | ₹81,396 Cr | 5.40 | |
| Mar2023 | ₹77,225 Cr | 15.33 | |
| Mar2022 | ₹66,958 Cr | 4.44 | |
| Mar2021 | ₹64,110 Cr | - | |
Compare Total Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,012.2 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
| MANKIND PHARMA | ₹85,816.7 Cr | 3% | -3.9% | -15.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -2.3% |
-8.5% |
-3% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses